Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Medical Journal
>
2007
>
120
>
7
Volume:
120
Issue:
7
1. Rapid development of late stent malappositon and coronary aneurysm following implantation of a paclitaxel-eluting coronary stent.
Page:614—616
2. Complication of interventional treatment: noncoronary sinus of Valsalva aneurysm ruptured into the right atrium.
Page:611—613
3. Carotid artery stenting in patients with coexistent carotid and coronary artery disease.
Page:608—610
4. Optimized cardiac resynchronization therapy in patients with congestive heart failure.
Page:605—607
5. Lymphogranuloma venereum caused by Chlamydia trachomatis serovar L3: a case report.
Page:601—604
6. Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction.
Page:598—600
7. Relationship between intravascular ultrasound imaging features of coronary plaques and soluble CD105 level in patients with coronary heart disease.
Page:595—597
8. Establishment and characterization of two new human embryonic stem cell lines, SYSU-1 and SYSU-2.
Page:589—594
9. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Page:584—588
10. Heat shock protein 70 gene transfection protects rat myocardium cell against anoxia-reoxygeneration injury.
Page:578—583
11. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Page:574—577
12. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Page:569—573
13. Left ventricular endocardial pacing predicts the reduction of left ventricular outflow tract pressure gradient immediately after percutaneous transseptal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Page:562—568
14. Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction.
Page:557—561
15. Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions.
Page:552—556
16. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions.
Page:545—551
17. Comparison of immediate and followup results between transradial and transfemoral approach for percutaneous coronary intervention in true bifurcational lesions.
Page:539—544
18. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study.
Page:533—538
19. Late stent thrombosis: a not negligible issue after drug-eluting stent implantation.
Page:531—532
